Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
2012
Switching from calcineurin inhibitors to sirolimus had an antitumoral effect among kidney-transplant recipients with previous squamous-cell carcinoma. These observations may have implications concerning immunosuppressive treatment of patients with cutaneous squamous-cell carcinomas. (Funded by Hospices Civils de Lyon and others; TUMORAPA ClinicalTrials.gov number, NCT00133887.).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
40
References
422
Citations
NaN
KQI